|
[Related PubMed/MEDLINE] Total Number of Papers: 363
|
|
|
[Display Entries]
|
>> all entries
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Activating transcription factor 2 (AccATF2) regulates tolerance to oxidative stress in Apis cerana cerana. |
AccATF2, bZIP, MDA |
2 |
2022 |
Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the WHSC1-mediated TOP2A/PI3K/AKT axis. |
HCC, WHSC1 |
3 |
2022 |
Adapalene induces adipose browning through the RARbeta-p38 MAPK-ATF2 pathway. |
AD, DIO, MAPK, RAR |
4 |
2022 |
Annexin A7 and JNK knockdown suppress the lymphatic metastasis potential of hepatocellular carcinoma cells: Possible contributions of ATF2 and sequence-related lncRNA NONMMUT114121.1. |
ANXA7, HCC, JNK, lnc, LNM |
5 |
2022 |
ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2. |
CRC, KO, TROP2 |
6 |
2022 |
Butorphanol reduces the neuronal inflammatory response and apoptosis via inhibition of p38/JNK/ATF2/p53 signaling. |
LPS, SCI |
7 |
2022 |
Changes of signaling molecules in the axotomized rat facial nucleus. |
CREB, ERK, IEGs, JNK, MAPKs, pCREB |
8 |
2022 |
CircFN1 upregulation initiated oxidative stress-induced apoptosis and inhibition of proliferation and migration in trophoblasts via circFN1-miR-19a/b-3p-ATF2 ceRNA network. |
ceRNA, MDA, miR, PE, ROC, SOD |
9 |
2022 |
CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR-153-3p/ATF2 axis and wnt/beta-catenin pathway. |
CC, circRNAs, circRNF121, EMT |
10 |
2022 |
GLUT3 Promotes Epithelial-Mesenchymal Transition via TGF-beta/JNK/ATF2 Signaling Pathway in Colorectal Cancer Cells. |
alpha-SMA, CRC, EMT, GLUT, JNK, PAI-1, TGF-beta, ZEB1 |
11 |
2022 |
Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. |
ARRB1, EVs, MAPK, MASP1 |
12 |
2022 |
lncRNA PINK1-AS Aggravates Cerebral Ischemia/Reperfusion Oxidative Stress Injury through Regulating ATF2 by Sponging miR-203. |
CI/R, PINK1-AS |
13 |
2022 |
Low-dose aspirin may prevent preeclampsia by inhibiting the expression of ATF2. |
--- |
14 |
2022 |
Mosloflavone-Resveratrol Hybrid TMS-HDMF-5z Exhibits Potent In Vitro and In Vivo Anti-Inflammatory Effects Through NF-kappaB, AP-1, and JAK/STAT Inactivation. |
AP-1, COX-2, IFN-beta, IKK, IL, iNOS, LPS, MAPK, MK2, NF-kappaB, TAK1, TNF-alpha |
15 |
2022 |
MYBPC1 is a key regulator for laryngeal carcinoma formation. |
MYBPC1 |
16 |
2022 |
NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathway. |
NEDD4L, PC, PCCs |
17 |
2022 |
Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK/ATF2 signaling pathways. |
AP, COX, IkappaB, IKK, IL, iNOS, LPS, MAPK, NF, NO, PGE2, TNF |
18 |
2022 |
Overexpression of Activating Transcription Factor-2 (ATF-2) Activates Wnt/Ca2+ Signaling Pathways and Promotes Proliferation and Invasion in Non-Small-Cell Lung Cancer. |
NSCLC |
19 |
2022 |
Protein disulfide-isomerase A3 knockdown attenuates oxidized low-density lipoprotein-induced oxidative stress, inflammation and endothelial dysfunction in human umbilical vein endothelial cells by downregulating activating transcription factor 2. |
HUVECs, ox-LDL, PDIA3 |
20 |
2022 |
Shexiang Baoxin Pill Regulates Intimal Hyperplasia, Migration, and Apoptosis after Platelet-Derived Growth Factor-BB-Stimulation of Vascular Smooth Muscle Cells via miR-451. |
BrdU, CCK-8, PDGF, PI, VSMCs |
21 |
2022 |
The two-faced role of ATF2 on cisplatin response in gastric cancer depends on p53 context. |
--- |
22 |
2022 |
Tonifying-Qi-and-Detoxification Decoction attenuated injuries of colon and lung tissues in ulcerative colitis rat model via regulating NF-kappaB and p38MAPK pathway. |
AECII, HE, IHC, NC, NF-kappaB, qRT-PCR, TEM, TQDD, UC |
23 |
2021 |
A Novel Small Peptide H-KI20 Inhibits Retinal Neovascularization Through the JNK/ATF2 Signaling Pathway. |
anti-VEGF, HRECs, JNK2 |
24 |
2021 |
ATF2 accelerates the invasion and metastasis of hepatocellular carcinoma through targeting the miR-548p/TUFT1 axis. |
HCC |
25 |
2021 |
ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM. |
HCC |
26 |
2021 |
C-type natriuretic peptide promotes adipogenic differentiation of goat adipose-derived stem cells via cGMP/PKG/ p38 MAPK signal pathway. |
ADSCs, CNP, MK2, NPR-B, p38 MAPK, PGC-1alpha, UCP1 |
27 |
2021 |
Combination of tetrandrine and 3-n-butylphthalide protects against cerebral ischemia-reperfusion injury via ATF2/TLR4 pathway. |
CI, I/R, NBP, TLR4, TTD |
28 |
2021 |
Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. |
HCC, MAPK14 |
29 |
2021 |
Cytochrome P450 2F2 (CYP2F2) negatively regulates browning in 3T3-L1 white adipocytes. |
beta3-AR, CYP2F2, p38 MAPK, PGC-1alpha, PKA, PRDM16, UCP1 |
30 |
2021 |
Decoding Cinnabarinic Acid-Specific Stanniocalcin 2 Induction by Aryl Hydrocarbon Receptor. |
AhR, CA, Dot1l, STC2, TCDD |
31 |
2021 |
Endoplasmic Reticulum Stress Induces CAP2 Expression Promoting Epithelial-Mesenchymal Transition in Liver Cancer Cells. |
CAP2, EMT, ER, PKCepsilon |
32 |
2021 |
G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related Phosphoproteomic Signatures in Renal Cell Carcinoma. |
GPER1, PI3K-AKT, RCC |
33 |
2021 |
Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis. |
control-ASO, HFHC, JNK, MAPK, NAFL, p-ATF2, p-JNK |
34 |
2021 |
Hydrogen sulfide of air induces macrophage extracellular traps to aggravate inflammatory injury via the regulation of miR-15b-5p on MAPK and insulin signals in trachea of chickens. |
DUSP1, GO, KEGG, METs, MPO |
35 |
2021 |
LncRNA GAS5 enhances radiosensitivity of hepatocellular carcinoma and restricts tumor growth and metastasis by miR-144-5p/ATF2. |
DLR, GAS5, HCC, RIP |
36 |
2021 |
Long non‑coding RNA ZSCAN16‑AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA‑451a and consequently increasing ATF2 expression. |
HCC, lncRNAs |
37 |
2021 |
MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2. |
HCC, MARCH6 |
38 |
2021 |
Micro-RNA-451 Reduces Proliferation of B-CPAP Human Papillary Thyroid Cancer Cells by Downregulating Expression of Activating Transcription Factor 2. |
3'UTR, miRNAs, mRNA, PTC |
39 |
2021 |
Monocyte-released HERV-K dUTPase engages TLR4 and MCAM causing endothelial mesenchymal transition. |
dUTPase, EndMT, EVs, MCAM, PA, PAECs, PAH |
40 |
2021 |
Protective effect of SIRT6 on cholesterol crystal-induced endothelial dysfunction via regulating ACE2 expression. |
Ang, CC, CVD, eNOS, HUVECs, NO |
41 |
2021 |
Pyruvate kinase M2 (PKM2) interacts with activating transcription factor 2 (ATF2) to bridge glycolysis and pyroptosis in microglia. |
LPS, PKM2 |
42 |
2021 |
Targeting Long Non-Coding RNA TTN-AS1 Suppresses Bladder Cancer Progression. |
BC, DFS, RT-PCR, TTN-AS1 |
43 |
2021 |
Tumor Necrosis Factor-alpha utilizes MAPK/NFkappaB pathways to induce cholesterol-25 hydroxylase for amplifying pro-inflammatory response via 25-hydroxycholesterol-integrin-FAK pathway. |
25-HC, C25H, FAK, TNF |
44 |
2020 |
6'-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK/miR-299-5p/ATF2 axis. |
AMPK, GPF, NSCLC, pAMPK, UTR |
45 |
2020 |
Activating transcription factor 2 (ATF2) negatively regulates the expression of antimicrobial peptide genes through tumor necrosis factor (TNF) in Macrobrachium nipponense. |
TNF |
46 |
2020 |
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. |
--- |
47 |
2020 |
D-serine Ameliorates Motor and Cognitive Impairments in beta-amyloid 1-42 Injected Mice by Inhibiting JNK Signaling Pathway. |
AD, BE, DAAO, GFAP, JNK, NMDAR1, p-JNK |
48 |
2020 |
Dichotomous engagement of HDAC3 activity governs inflammatory responses. |
HDACs |
49 |
2020 |
Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells. |
LUAD, miR-26b-5p |
50 |
2020 |
Indomethacin decreases insulin secretion by reducing KCa3.1 as a biomarker of pancreatic tumor and causes apoptotic cell death. |
GLUT2, IR |
51 |
2020 |
M2 Macrophage-Derived Exosomal lncRNA AFAP1-AS1 and MicroRNA-26a Affect Cell Migration and Metastasis in Esophageal Cancer. |
EC, lncRNAs, miR-26a |
52 |
2020 |
Mechanisms underlying the promotion of osteosarcoma cell proliferation and invasion by lncRNA PBB12. |
KLF4, lncRNA |
53 |
2020 |
Mechano growth factor pretreatment yield mechanical stimuli induced cell stress responses in ligament fibroblasts of osteoarthritis via activating ATF-2. |
MGF, OA-LFs |
54 |
2020 |
miR-181a and miR-203 inhibit migration and invasion of laryngeal carcinoma cells by interacting with ATF2. |
LC, miRNAs, RIP |
55 |
2020 |
miR-602 Mediates the RASSF1A/JNK Pathway, Thereby Promoting Postoperative Recurrence in Nude Mice with Liver Cancer. |
JNK, RASSF1A |
56 |
2020 |
miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis. |
BilIN, dCCA |
57 |
2020 |
Mycosporine-like amino acids stimulate hyaluronan secretion by up-regulating hyaluronan synthase 2 via activation of the p38/MSK1/CREB/c-Fos/AP-1 axis. |
CREB, ERK, HA, HAS2, JNK, MAAs, MAPK, MEK, MSK1 |
58 |
2020 |
Negative regulation of IL-8 in human astrocytes depends on beta-catenin while positive regulation is mediated by TCFs/LEF/ATF2 interaction. |
--- |
59 |
2020 |
PNU-120596, a positive allosteric modulator of alpha7 nicotinic acetylcholine receptor, directly inhibits p38 MAPK. |
alpha7nAChR, MAPK, MLA, PAM |
60 |
2020 |
SET8 participates in lipopolysaccharide-mediated BV2 cell inflammation via modulation of TICAM-2 expression. |
LPS, TICAM-2 |
61 |
2020 |
SpATF2 participates in maintaining the homeostasis of hemolymph microbiota by regulating dual oxidase expression in mud crab. |
MAPK, RNAi |
62 |
2020 |
Sprouty2 Inhibits Migration and Invasion of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis by Down-regulating ATF2 Expression and Phosphorylation. |
RA, RA-FLS, Spry2 |
63 |
2020 |
The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression. |
AP-1, LUAD |
64 |
2020 |
The Ras-ERK signaling pathway regulates acetylated activating transcription factor 2 via p300 in pancreatic cancer cells. |
ChIP, ERK, MDM2 |
65 |
2020 |
The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation. |
BAT |
66 |
2020 |
Ubiquitin-specific protease 14 promotes prostate cancer progression through deubiquitinating the transcriptional factor ATF2. |
USP14 |
67 |
2019 |
A temperature-dependent conformational shift in p38alpha MAPK substrate-binding region associated with changes in substrate phosphorylation profile. |
HDX-MS, MAPK, MK2, STAT1alpha, TNF-alpha |
68 |
2019 |
CID-6033590 inhibits p38MAPK pathway and induces S-phase cell cycle arrest and apoptosis in DU145 and PC-3 cells. |
HSP27, P-p38, PARP |
69 |
2019 |
Deficiency in intestinal epithelial Reg4 ameliorates intestinal inflammation and alters the colonic bacterial composition. |
DSS, IF, IL-6, Reg4, STAT3, TNF-alpha |
70 |
2019 |
Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach. |
ABCG2, BRCA1, CC, CRC, CYP19A1, DisGeNET, EGFR, ESR1, ESR2, FOXA1, PPI |
71 |
2019 |
ERK1/ATF-2 signaling axis contributes to interleukin-1beta-induced MMP-3 expression in dermal fibroblasts. |
ECM, ERK, MMPs |
72 |
2019 |
GDF5 Promotes White Adipose Tissue Thermogenesis via p38 MAPK Signaling Pathway. |
FABP4, GDF5, HFD, MAPK, sWAT, Tg |
73 |
2019 |
Identification of biomarkers associated with the recurrence of osteosarcoma using ceRNA regulatory network analysis. |
ce, GEO, GSEA, lnc, mi, PPM1B, RAP1B, SNHG1 |
74 |
2019 |
Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes. |
CETSA, IL-6, JNK, MAPK, MMPs, RA-FLSs |
75 |
2019 |
Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis. |
CIDEA, HFD, KO, MAPK, PPARgamma, WT |
76 |
2019 |
Quercetin Inhibits the Production of IL-1beta-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-kappaB Signaling Pathways. |
CREB, ERK, ICAM-1, IKK, IL-1beta, JNK, MAPKs, MCP-1, MMP-9, NF, sICAM-1, TNF-alpha |
77 |
2019 |
The activating transcription factor 2: an influencer of cancer progression. |
CRC |
78 |
2019 |
The role of NF-kappaB-mediated JNK pathway in cognitive impairment in a rat model of sleep apnea. |
CIH, IL-6, iNOS, JNK, MDA, NF-kappaB, NS, SA, SH, SOD, TNF-alpha |
79 |
2019 |
TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation. |
CNS |
80 |
2018 |
Association between the rs7583431 single nucleotide polymorphism close to the activating transcription factor 2 gene and the analgesic effect of fentanyl in the cold pain test. |
SNPs |
81 |
2018 |
ATF2, but not ATF3, participates in the maintenance of nerve injury-induced tactile allodynia and thermal hyperalgesia. |
--- |
82 |
2018 |
Effects of exercise in a cold environment on transcriptional control of PGC-1alpha. |
CREB, ERRalpha, MEF2A, NRF1 |
83 |
2018 |
Hippocampal CA1 betaCaMKII mediates neuroinflammatory responses via COX-2/PGE2 signaling pathways in depression. |
AAV, betaCaMKII, COX, CUMS, LPS, MAPK, PGE2 |
84 |
2018 |
Maternal Protein Restriction Induces Alterations in Hepatic Unfolded Protein Response-Related Molecules in Adult Rat Offspring. |
CREB3L3, Ern2, Hspa4l, IUGR, Mapk10, qPCR, UPR |
85 |
2018 |
miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2. |
NSCLC |
86 |
2018 |
MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2. |
NSCLC, qRT-PCR |
87 |
2018 |
miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy. |
4-HNE, miR-451a, PDR |
88 |
2018 |
Proprotein convertase subtilisin/kexin type 9 inhibits interferon beta expression through interacting with ATF-2. |
IFN, PCSK9 |
89 |
2018 |
Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun. |
Bcl-xL, miRNAs |
90 |
2018 |
Regulation by Pink1 on the mitochondrial dysfunction in endothelial cells post the hypoxia mimetic agent CoCl2 treatment. |
NSCLC, qRT-PCR |
91 |
2018 |
Shotgun Proteomics and Quantitative Pathway Analysis of the Mechanisms of Action of Dehydroeffusol, a Bioactive Phytochemical with Anticancer Activity from Juncus effusus. |
DHE, JNK |
92 |
2018 |
Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells. |
HCC, siRNA, TNF |
93 |
2018 |
Soluble syntaxin 3 functions as a transcriptional regulator. |
ETV4 |
94 |
2018 |
The involvement of p38MAPK in the rat model of lower-extremity arterial ischemia-reperfusion injury. |
p38 MAPK, SD, TUNEL |
95 |
2018 |
Transcriptional activation of miR-320a by ATF2, ELK1 and YY1 induces cancer cell apoptosis under ionizing radiation conditions. |
IR, MAPK, XIAP, YY1 |
96 |
2018 |
Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIdelta expression in the aged atrium. |
JNK, JNK2 |
97 |
2017 |
Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: An in vivo and in vitro study. |
AAT, CCK-8, ChIP, ELISA, MDA, NP, p38 MAPK, PE, qRT-PCR, ROS, SOD, STAT1, TUNEL |
98 |
2017 |
ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors' secretion in arsenite-treated human uroepithelial cells. |
iAs |
99 |
2017 |
ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease. |
--- |
100 |
2017 |
Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling. |
ChIP, ERK, ICC, IHC, JNK, PTHLH |
|